Prognostic implications of PET-derived tumor volume and uptake in patients with neuroendocrine tumors
M Weber, T Telli, D Kersting, R Seifert - Cancers, 2023 - mdpi.com
Simple Summary The monitoring of disease in patients with neuroendocrine tumors is
challenging and requires specialized imaging techniques. To address these quests …
challenging and requires specialized imaging techniques. To address these quests …
Role of PET/CT and therapy management of pancreatic neuroendocrine tumors
D Calabrò, G Argalia, V Ambrosini - Diagnostics, 2020 - mdpi.com
Pancreatic neuroendocrine neoplasms (panNENs) are heterogeneous neoplasms with
neuroendocrine differentiation that show peculiar clinical and histomorphological features …
neuroendocrine differentiation that show peculiar clinical and histomorphological features …
Semiautomatic tumor delineation for evaluation of 64Cu-DOTATATE PET/CT in patients with neuroendocrine neoplasms: prognostication based on lowest lesion …
EA Carlsen, CB Johnbeck, M Loft… - Journal of Nuclear …, 2021 - Soc Nuclear Med
Patients with neuroendocrine neoplasms (NENs) have heterogeneous somatostatin
receptor expression, with highly differentiated lesions having higher expression. Receptor …
receptor expression, with highly differentiated lesions having higher expression. Receptor …
A convolutional neural network for total tumor segmentation in [64Cu]Cu-DOTATATE PET/CT of patients with neuroendocrine neoplasms
EA Carlsen, K Lindholm, A Hindsholm, M Gæde… - EJNMMI research, 2022 - Springer
Background Segmentation of neuroendocrine neoplasms (NENs) in [64Cu] Cu-DOTATATE
positron emission tomography makes it possible to extract quantitative measures useable for …
positron emission tomography makes it possible to extract quantitative measures useable for …
Prognostic value of volume-based parameters measured by SSTR PET/CT in neuroendocrine tumors: a systematic review and meta-analysis
J Hou, Y Yang, N Chen, D Chen, S Hu - Frontiers in Medicine, 2021 - frontiersin.org
Purpose: A meta-analysis was conducted to investigate the value of the volume parameters
based on somatostatin receptor (SSTR)-positron emission tomography (PET) in predicting …
based on somatostatin receptor (SSTR)-positron emission tomography (PET) in predicting …
The quest for an accurate functional tumor volume with 68Ga-DOTATATE PET/CT
RP Reddy, CR Schmidtlein, RG Giancipoli… - Journal of Nuclear …, 2022 - Soc Nuclear Med
68Ga-labeled somatostatin analog (SSA) PET/CT is now a standard-of-care component in
the management of neuroendocrine tumors (NETs). However, treatment response for NETs …
the management of neuroendocrine tumors (NETs). However, treatment response for NETs …
Prognostic value of whole-body PET volumetric parameters extracted from 68Ga-DOTATOC PET/CT in well-differentiated neuroendocrine tumors
P Thuillier, V Liberini, S Grimaldi… - Journal of Nuclear …, 2022 - Soc Nuclear Med
Our objective was to evaluate the prognostic value of somatostatin receptor tumor burden on
68Ga-DOTATOC PET/CT in patients with well-differentiated (WD) neuroendocrine tumors …
68Ga-DOTATOC PET/CT in patients with well-differentiated (WD) neuroendocrine tumors …
Ga-68-Edotreotide Positron Emission Tomography/Computed Tomography Somatostatin Receptors Tumor Volume Predicts Outcome in Patients With Primary …
R Gallicchio, A Giordano, M Milella, R Storto… - Cancer …, 2023 - journals.sagepub.com
Background We retrospectively aimed to assess the prognostic significance of somatostatin
receptor (SSTR) standardized uptake value (SUVmaxsstr), SSTR representative tumor …
receptor (SSTR) standardized uptake value (SUVmaxsstr), SSTR representative tumor …
Predictive value of 68 [Ga] Ga-DOTA-TATE PET/CT volumetric parameters in assessing treatment response to long-acting somatostatin analogues in patients with well …
K Morawiec-Sławek, M Opalińska, W Lenda-Tracz… - EJNMMI research, 2024 - Springer
Background Over the past decade, numerous treatment options have emerged for patients
with locally advanced and metastatic neuroendocrine tumours (NETs). Nevertheless, the …
with locally advanced and metastatic neuroendocrine tumours (NETs). Nevertheless, the …
(Radio) theranostic patient management in oncology exemplified by neuroendocrine neoplasms, prostate cancer, and breast cancer
I Velikyan - Pharmaceuticals, 2020 - mdpi.com
The role of nuclear medicine in the management of oncological patients has expanded
during last two decades. The number of radiopharmaceuticals contributing to the realization …
during last two decades. The number of radiopharmaceuticals contributing to the realization …